A Proposed Screening Paradigm for Discovery of Covalent Inhibitor Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|8|1|19-30

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.8, Iss.1, 2014-06, pp. : 19-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug discovery for a new generation of covalent drugs

By Kalgutkar Amit S   Dalvie Deepak K  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 7, 2012-07 ,pp. : 561-581

Informa Healthcare

Access to resources Recommend Favorite

Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 3-16

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Thrombin Inhibitor Fragments from Chemical Microarray Screening

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 8, 2005-12 ,pp. : 590-594

Bentham Science Publishers

Access to resources Recommend Favorite

Gene expression profiling in the discovery, optimization and development of novel drugs: one universal screening platform

By Bol David   Ebner Reinhard  

Pharmacogenomics, Vol. 7, Iss. 2, 2006-03 ,pp. : 227-235

Future Medicine

Access to resources Recommend Favorite

Editorial [Hot Topic:Current Antiparasitic Drug Targets and a Paradigm Shift in Discovery of New Antiparasitic Drugs and Vaccines(Guest Editor: Babu L. Tekwani)

By  

Current Drug Targets, Vol. 9, Iss. 11, 2008-11 ,pp. : 921-921

Bentham Science Publishers

Access to resources Recommend Favorite